Leadership Overview
Neuland Laboratories has 7 executives leading key functions including strategy, information technology, operations, human resources, medical affairs, business development, and marketing.
Driven by innovation, Neuland Laboratories is dedicated to advancing drug development and cGMP manufacturing of APIs, leveraging strong process chemistry to provide reliable solutions to the global pharmaceutical industry.
Driven by innovation, Neuland Laboratories is dedicated to advancing drug development and cGMP manufacturing of APIs, leveraging strong process chemistry to provide reliable solutions to the global pharmaceutical industry.
Leadership Roles at Neuland Laboratories
Saharsh Davuluri - Chief Executive Officer & Managing Director
Saharsh Davuluri, the Chief Executive Officer & Managing Director at Neuland Laboratories, directs the company's overall strategic vision and operational execution. Davuluri guides Neuland's mission to accelerate drug development and cGMP manufacturing of Active Pharmaceutical Ingredients (APIs). This leadership role involves fostering innovation in process chemistry and ensuring adherence to stringent regulatory environments. Overseeing global operations, the Chief Executive Officer & Managing Director ensures alignment with corporate objectives and market demands. By driving strategic initiatives, Saharsh Davuluri directly impacts the company's growth and its position as an end-to-end solution provider for the pharmaceutical industry. Ultimately, Davuluri secures Neuland Laboratories' long-term success and market leadership.
Shashank Mahashabde - Contract Manufacturing President, Business Development
Shashank Mahashabde, the Contract Manufacturing President, Business Development at Neuland Laboratories, drives strategic partnerships and expands the company's contract manufacturing services. Mahashabde focuses on leveraging Neuland's strong process chemistry capabilities to secure new business opportunities within the global pharmaceutical industry. This leadership role involves identifying market needs and aligning Neuland's end-to-end solutions to meet client requirements for API development and cGMP manufacturing. By cultivating relationships and exploring new ventures, the Contract Manufacturing President, Business Development enhances Neuland Laboratories' revenue streams and market reach. Shashank Mahashabde's efforts are crucial for driving growth and solidifying Neuland's reputation as a premier manufacturing partner.
Ajitabh Singh - Chief Information Officer
Ajitabh Singh, the Chief Information Officer at Neuland Laboratories, architects the company's technology infrastructure and digital strategy. Singh oversees the integration of advanced IT solutions to support Neuland's core competencies in process chemistry and API manufacturing. This role is critical for enhancing operational efficiency and ensuring data security across all business functions. By implementing robust information systems, the Chief Information Officer facilitates seamless communication and collaboration among scientific and technical teams globally. Ajitabh Singh's leadership ensures that technology empowers Neuland Laboratories' commitment to reliable solutions and regulatory compliance. Ultimately, Singh drives digital transformation to support the company's growth and innovation in the pharmaceutical sector.
Raja Shekar - Deputy Manager, Material Planning & Chief Marketing Officer
Raja Shekar, the Deputy Manager, Material Planning & Chief Marketing Officer at Neuland Laboratories, manages critical supply chain logistics and spearheads market outreach initiatives. Shekar ensures the efficient planning and procurement of raw materials essential for API manufacturing, directly supporting Neuland's production capabilities. Concurrently, as Chief Marketing Officer, Raja Shekar develops and executes strategies to enhance Neuland Laboratories' global market presence and brand recognition. This dual focus ensures operational continuity while driving business development and customer engagement. By optimizing material flow and amplifying market impact, Shekar contributes significantly to the company's ability to deliver end-to-end solutions. Raja Shekar's leadership bridges operational needs with strategic market positioning.
Hemchandra Peruvelli - Chief Human Resources Officer
Hemchandra Peruvelli, the Chief Human Resources Officer at Neuland Laboratories, cultivates a high-performance organizational culture and manages talent acquisition and development. Peruvelli oversees all human capital strategies, ensuring Neuland Laboratories attracts, retains, and develops the skilled scientific and technical professionals vital to its success. This leadership position involves fostering an environment that supports innovation and adherence to cGMP manufacturing standards. By championing employee engagement and professional growth, the Chief Human Resources Officer ensures the workforce is equipped to meet the evolving demands of the pharmaceutical industry. Hemchandra Peruvelli's strategic HR initiatives are fundamental to Neuland's operational excellence and its reputation for providing reliable solutions.
Adrian Monk - Chief Medical Officer
Adrian Monk, the Chief Medical Officer at Neuland Laboratories, provides critical medical and scientific expertise to guide drug development and regulatory strategy. Monk ensures that Neuland's API manufacturing processes and services align with the highest standards of pharmaceutical efficacy and patient safety. This role is pivotal in bridging scientific research with commercial manufacturing, particularly in complex chemistry-related services. By offering insights into clinical requirements and regulatory landscapes, the Chief Medical Officer supports Neuland Laboratories' commitment to facilitating drug development. Adrian Monk's guidance is instrumental in maintaining Neuland's position as a trusted partner for global pharmaceutical companies seeking reliable solutions.
Dorothy Paul - Chief Marketing & Communications Officer
Dorothy Paul, the Chief Marketing & Communications Officer at Neuland Laboratories, shapes the company's brand narrative and enhances its global market presence. Paul directs strategic communication initiatives, ensuring Neuland Laboratories' expertise in API manufacturing and process chemistry is effectively conveyed to stakeholders worldwide. This role is essential for building brand equity and fostering strong relationships within the pharmaceutical industry. By articulating Neuland's value proposition and commitment to reliable solutions, the Chief Marketing & Communications Officer supports business development objectives. Dorothy Paul's leadership ensures consistent messaging that reinforces Neuland's position as a leading end-to-end solution provider. Paul's strategic communications drive market engagement and brand recognition.
Explore Leadership Teams in Manufacturing
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia.
Company Leadership
AB
SS
Gufic Group is a respected player in the pharmaceutical industry, established in 1970, known for its innovative and high-quality pharmaceutical and herbal products, along with a diverse range of APIs. They are recognized as one of India's largest manufacturers of lyophilized injections, offering a variety of products including antibiotics, antifungals, and antiviral treatments. Their extensive network facilitates the supply of these products to major hospital chains and leading medical facilities across India. Gufic is committed to research and development, continuously launching advanced new products while expanding their international footprint.
Company Leadership DR
RK
NY
SD
Founded in 1967, Douglas Pharmaceuticals is a manufacturer of pharmaceutical products. The company started out distributing prescription medicines, before manufacturing and later successfully researching and developing its products for export. The company is headquartered in Auckland, New Zealand.
Company Leadership SW
BL
CR
TB
Grupo NC is a leading Brazilian pharmaceutical company with roots dating back to 2014 when it began as a small pharmacy in Santo André. Officially founded in 1964 with its first factory in São Bernardo do Campo, the company has grown to become one of the largest pharmaceutical industries in Brazil. Grupo NC operates with a dual business model serving both B2B and B2C markets, offering innovative healthcare solutions and pharmacy retail services. The company maintains a strong presence in South America, particularly Brazil, while also expanding into Asian markets. Grupo NC is committed to sustainable development, innovation in healthcare solutions, and excellence in all operational aspects. The company's core values emphasize continuous improvement, responsible innovation, and making a positive impact in the markets where they operate.
Company Leadership ND
DM
Frequently Asked Questions Regarding Neuland Laboratories Top Executives and Leadership Team
